In the present study, we reported that RNase L, an endoribonuclease of 2–5A/RNase L system in IFN-mediated antiviral signaling, is upregulated with impaired function in lung cancer cells due to altered coordination between RNase L and its inhibitor, RLI. The gene discussed is IFNA1; the disease is lung carcinoma.